Regardless of whether Sema4B was intact or lost within the glioma CRISPR clones (in control clones or deleted ones), all lines responded similarly when treated with sh-SM4Bs (one infecting unit/cell as determined by testing parental U87MG). This evidence concerns the gene SEMA4B and glioma.